Sign in

CIK 0001651625 · Accelerated filer

AC Immune SA

Sign in to watch
Ticker
ACIU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Switzerland
Entity type
other
Phone
41 21 345 91 21
Business address
EPFL INNOVATION PARK, BUILDING B, 1015 LAUSANNE, Switzerland, 00000
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-11 Twyman Roy Ervin Director Grant or award +16,568 92,556
2026-06-11 Twyman Roy Ervin Director Grant or award · Share Option (right to buy) +38,889 38,889
2026-06-11 AGUIAR-LUCANDER RENEE Director Grant or award +16,568 51,136
2026-06-11 AGUIAR-LUCANDER RENEE Director Grant or award · Share Option (right to buy) +38,889 38,889
2026-06-11 Zuegel Martin Interim CEO Grant or award +33,136 71,408
2026-06-11 Zuegel Martin Interim CEO Grant or award · Share Option (right to buy) +77,778 77,778
2026-06-11 Buetler Monika Director Grant or award +17,751 71,656
2026-06-11 Buetler Monika Director Grant or award · Share Option (right to buy) +41,667 41,667
2026-06-11 June Carl Howard Director Grant or award +16,568 67,556
2026-06-11 June Carl Howard Director Grant or award · Share Option (right to buy) +38,889 38,889
2026-05-15 Pfeifer Andrea Chief Executive Officer Sale 10b5-1 −10,000 $2.79 $28K 3,820,288
2026-04-15 Pfeifer Andrea Chief Executive Officer Sale 10b5-1 −10,000 $3.14 $31K 3,830,288
2026-04-15 Pfeifer Andrea Chief Executive Officer Purchase 10b5-1 −10,000 $3.14 $31K 3,830,288

Page 1 of 1 · 13 trades